Clinical Trials on 乳腺癌模型 in China
总计7376个结果
-
The First Affiliated Hospital with Nanjing Medical...未知阿帕替尼联合白蛋白紫杉醇和卡铂方案用于三阴性乳腺癌新辅助治疗的 pCR 率的系统评价中国
-
Jiangsu HengRui Medicine Co., Ltd.邀请报名
-
The First Affiliated Hospital of Xinxiang Medical...AstraZeneca招聘中
-
Cancer Institute and Hospital, Chinese Academy...Questgenomics未知
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering Institute完全的
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.未知
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University尚未招聘绝经前乳腺癌 | 激素受体阳性乳腺癌 | 中高危乳腺癌患者 | 卵巢功能抑制联合芳香化酶抑制剂或他莫昔芬或托瑞美芬中国
-
Peking University Cancer Hospital & Institute招聘中HER2阳性转移性乳腺癌 | 以前接受过曲妥珠单抗治疗 | 曲妥珠单抗联合帕妥珠单抗和化疗中国
-
CASI Pharmaceuticals, Inc.University of Colorado, Denver; Indiana University Melvin and Bren Simon Cancer Center完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University未知
-
Fudan University终止
-
Zhejiang Cancer Hospital招聘中晚期 HR 阳性和 HER2 阴性乳腺癌; CDK4/6抑制剂治疗失败中国
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Shanghai Pudong HospitalCSPC Ouyi Pharmaceutical Co., Ltd.招聘中
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
Cancer Institute and Hospital, Chinese Academy...CSPC Ouyi Pharmaceutical Co., Ltd.尚未招聘
-
Tianjin Hemay Oncology Pharmaceutical Co., Ltd招聘中
-
Tianjin Medical University Cancer Institute and...招聘中